CVRx (CVRX) Cash from Investing Activities (2020 - 2026)
CVRx (CVRX) posted quarterly Cash from Investing Activities of -$122000.0 for Q1 2026, down 7.02% year-over-year from -$131207.5 in Q1 2025, and down 79.41% quarter-over-quarter from -$68000.0 in Q4 2025.
CVRx (CVRX) Cash from Investing Activities (2020 - 2026) Analysis & Trends
CVRx's Cash from Investing Activities history runs 7 years deep, the most recent figure standing at -$122000.0 for Q1 2026.
- In Q1 2026, Cash from Investing Activities fell 7.02% year-over-year to -$122000.0; the TTM figure through Mar 2026 stood at -$588000.0 (down 5.38% YoY), while the FY2025 annual figure was -$580000.0, up 57.38% from the prior year.
- Cash from Investing Activities for Q1 2026 stood at -$122000.0, down from -$68000.0 in the prior quarter.
- The five-year high for Cash from Investing Activities was -$37000.0 in Q3 2024, with the low at -$917000.0 in Q1 2024.
- The 5-year median for Cash from Investing Activities is -$122000.0 (2026), against an average of -$196411.8.
- Peak annual rise in Cash from Investing Activities reached 87.57% in 2025, while the deepest fall reached 697.3% in 2025.
- CVRx's Cash from Investing Activities stood at -$79000.0 in 2022, then plunged by 113.92% to -$169000.0 in 2023, then jumped by 69.23% to -$52000.0 in 2024, then tumbled by 30.77% to -$68000.0 in 2025, then tumbled by 79.41% to -$122000.0 in 2026.
- Business Quant data shows CVRX's Cash from Investing Activities at -$122000.0 in Q1 2026, -$68000.0 in Q4 2025, and -$295000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.07 Bn | 193.46 Bn | 7.27 Bn | -673.00 Mn |
| 2 | Stryker | 127.90 Bn | 124.43 Bn | 4.50 Bn | -639.00 Mn |
| 3 | Medtronic | 118.84 Bn | 109.62 Bn | 6.41 Bn | -917.00 Mn |
| 4 | Boston Scientific | 73.33 Bn | 72.79 Bn | 3.85 Bn | -1.96 Bn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | -193.20 Mn |
| 6 | Dexcom | 34.46 Bn | 32.51 Bn | 830.00 Mn | 329.80 Mn |
| 7 | GE HealthCare Technologies | 33.91 Bn | 31.81 Bn | 2.18 Bn | -115.00 Mn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | -22.08 Mn |
| 9 | Steris | 23.12 Bn | 22.64 Bn | 684.20 Mn | -108.50 Mn |
| 10 | CVRx | 76.89 Mn | 12.31 Mn | 13.72 Mn | -112,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -112,000.00 |
| Jun 30, 2026 | -112,000.00 |
| Mar 31, 2026 | -122,000.00 |
| Mar 31, 2026 | -122,000.00 |
| Dec 31, 2025 | -68,000.00 |
| Dec 31, 2025 | -68,000.00 |
| Sep 30, 2025 | -295,000.00 |
| Sep 30, 2025 | -295,000.00 |
| Jun 30, 2025 | -103,000.00 |
| Jun 30, 2025 | -103,000.00 |
| Mar 31, 2025 | -114,000.00 |
| Mar 31, 2025 | -114,000.00 |
| Dec 31, 2024 | -52,000.00 |
| Dec 31, 2024 | -52,000.00 |
| Sep 30, 2024 | -37,000.00 |
| Sep 30, 2024 | -37,000.00 |
| Jun 30, 2024 | -355,000.00 |
| Jun 30, 2024 | -355,000.00 |
| Mar 31, 2024 | -917,000.00 |
| Mar 31, 2024 | -917,000.00 |